15 Jan, 2015

New CEO in office

As previously announced Dr. Mats Hansen has been appointed new CEO of Spago Nanomedical. Dr. Hansen has now assumed position and taken over operational lead of the company from Andreas Bunge. “I´m very excited to join Spago at a point when Spago Pix is entering into development phase and Tumorad is in the pipeline. Both projects address areas of major clinical needs and have the potential to reach significant and growing markets. I would like to thank Andreas Bunge for his previous and continued engagement in the company and look forward to contribute to the future development of the company.” says Dr. Hansen.